A carregar...

Cost-Effectiveness of HIV Preexposure Prophylaxis for People Who Inject Drugs in the United States

BACKGROUND: The total population health benefits and costs of HIV preexposure prophylaxis (PrEP) for people who inject drugs (PWID) in the United States are unclear. OBJECTIVE: To evaluate the cost-effectiveness and optimal delivery conditions of PrEP for PWID. DESIGN: Empirically calibrated dynamic...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Intern Med
Main Authors: Bernard, Cora L., Brandeau, Margaret L., Humphreys, Keith, Bendavid, Eran, Holodniy, Mark, Weyant, Christopher, Owens, Douglas K., Goldhaber-Fiebert, Jeremy D.
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5118181/
https://ncbi.nlm.nih.gov/pubmed/27110953
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7326/M15-2634
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!